Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Momenta Pharmaceuticals Company Profile (NASDAQ:MNTA)

Consensus Ratings for Momenta Pharmaceuticals (NASDAQ:MNTA) (?)
Ratings Breakdown: 1 Sell Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $19.20 (73.29% upside)

Current Analysts' Coverage Summary for Momenta Pharmaceuticals (NASDAQ:MNTA)
Show:
DateFirmActionRatingPrice TargetDetailsShare
6/5/2014Maxim GroupInitiated CoverageBuy$24.00 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
6/2/2014Goldman SachsInitiated CoverageBuy$19.00ViewTweet This Rating  Share This Rating on StockTwits
5/7/2014Bank of AmericaUpgradeUnderperform -> BuyViewTweet This Rating  Share This Rating on StockTwits
5/7/2014Canaccord GenuityReiterated RatingBuy$22.00 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
3/5/2014TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
11/5/2013Sanford C. BernsteinBoost Price TargetOutperform$20.00 -> $24.00ViewTweet This Rating  Share This Rating on StockTwits
10/14/2013R. F. LaffertyInitiated CoverageBuy$19.00ViewTweet This Rating  Share This Rating on StockTwits
6/18/2013WallachBeth CapitalReiterated RatingBuy$17.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/31/2012 forward)